IT1300055B1 - Eterocicli con anello a 5 termini difenil-sostituiti loro procedimento di preparazione e loro impiego come farmici - Google Patents

Eterocicli con anello a 5 termini difenil-sostituiti loro procedimento di preparazione e loro impiego come farmici

Info

Publication number
IT1300055B1
IT1300055B1 IT98MI000818A ITMI980818A IT1300055B1 IT 1300055 B1 IT1300055 B1 IT 1300055B1 IT 98MI000818 A IT98MI000818 A IT 98MI000818A IT MI980818 A ITMI980818 A IT MI980818A IT 1300055 B1 IT1300055 B1 IT 1300055B1
Authority
IT
Italy
Prior art keywords
heterocycles
diphenyl
drugs
substituted
preparation procedure
Prior art date
Application number
IT98MI000818A
Other languages
English (en)
Italian (it)
Inventor
Enzo Cereda
Carlo Maria Pellegrini
Maura Bignotti
Michael Brenner
Marion Wienrich
Thomas Weiser
Wolf-Dietrich Bechtel
Rainer Palluk
Original Assignee
Boehringer Ingelheim Italia
Boehringer Ingelheim Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Italia, Boehringer Ingelheim Pharma filed Critical Boehringer Ingelheim Italia
Priority to DE19816880A priority Critical patent/DE19816880A1/de
Priority to IT98MI000818A priority patent/IT1300055B1/it
Priority to US09/290,931 priority patent/US6255327B1/en
Priority to DE59909917T priority patent/DE59909917D1/de
Priority to JP2000544653A priority patent/JP4589531B2/ja
Priority to ES99920661T priority patent/ES2224652T3/es
Priority to CA002322195A priority patent/CA2322195C/en
Priority to PCT/EP1999/002496 priority patent/WO1999054314A1/de
Priority to AT99920661T priority patent/ATE270665T1/de
Priority to MXPA00009474A priority patent/MXPA00009474A/es
Priority to EP99920661A priority patent/EP1071670B1/de
Publication of ITMI980818A1 publication Critical patent/ITMI980818A1/it
Application granted granted Critical
Publication of IT1300055B1 publication Critical patent/IT1300055B1/it

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/32—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D207/33—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D207/333—Radicals substituted by oxygen or sulfur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D231/18—One oxygen or sulfur atom
    • C07D231/20—One oxygen atom attached in position 3 or 5
    • C07D231/22—One oxygen atom attached in position 3 or 5 with aryl radicals attached to ring nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
    • C07D261/06—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
    • C07D261/08—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D263/32—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Vascular Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pyrrole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
IT98MI000818A 1998-02-01 1998-04-17 Eterocicli con anello a 5 termini difenil-sostituiti loro procedimento di preparazione e loro impiego come farmici IT1300055B1 (it)

Priority Applications (11)

Application Number Priority Date Filing Date Title
DE19816880A DE19816880A1 (de) 1998-04-17 1998-04-17 Neue Diphenyl-substituierte 5-Ring-Heterocyclen, Verfahren zu ihrer Herstellung sowie deren Verwendung als Arzneimittel
IT98MI000818A IT1300055B1 (it) 1998-04-17 1998-04-17 Eterocicli con anello a 5 termini difenil-sostituiti loro procedimento di preparazione e loro impiego come farmici
US09/290,931 US6255327B1 (en) 1998-02-01 1999-04-13 Diphenyl-substituted heterocycles, processes for preparing them and their use as pharmaceutical compositions
JP2000544653A JP4589531B2 (ja) 1998-04-17 1999-04-14 新規ジフェニル置換５員環複素環化合物、それらの製造方法及び薬物としてのそれらの使用
DE59909917T DE59909917D1 (de) 1998-04-17 1999-04-14 Diphenyl-substituierte 5-ring-heterocyclen, verfahren zu ihrer herstellung sowie deren verwendung als arzneimittel
ES99920661T ES2224652T3 (es) 1998-04-17 1999-04-14 Heterociclos de 5 anillos sustituidos con difenilo, procedimiento para su preparacion, asi como su empleo como medicamentos.
CA002322195A CA2322195C (en) 1998-04-17 1999-04-14 Novel diphenyl-substituted 5-ring-heterocycles, method for producing them and their use as medicaments
PCT/EP1999/002496 WO1999054314A1 (de) 1998-04-17 1999-04-14 Neue diphenyl-substituierte 5-ring-heterocyclen, verfahren zu ihrer herstellung sowie deren verwendung als arzneimittel
AT99920661T ATE270665T1 (de) 1998-04-17 1999-04-14 Diphenyl-substituierte 5-ring-heterocyclen, verfahren zu ihrer herstellung sowie deren verwendung als arzneimittel
MXPA00009474A MXPA00009474A (es) 1998-04-17 1999-04-14 Nuevos heterociclos de 5 anillos sustituidos con difenilo, procedimientos para su preparacion, asi como su empleo como medicamentos.
EP99920661A EP1071670B1 (de) 1998-04-17 1999-04-14 Diphenyl-substituierte 5-ring-heterocyclen, verfahren zu ihrer herstellung sowie deren verwendung als arzneimittel

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19816880A DE19816880A1 (de) 1998-04-17 1998-04-17 Neue Diphenyl-substituierte 5-Ring-Heterocyclen, Verfahren zu ihrer Herstellung sowie deren Verwendung als Arzneimittel
IT98MI000818A IT1300055B1 (it) 1998-04-17 1998-04-17 Eterocicli con anello a 5 termini difenil-sostituiti loro procedimento di preparazione e loro impiego come farmici

Publications (2)

Publication Number Publication Date
ITMI980818A1 ITMI980818A1 (it) 1999-10-17
IT1300055B1 true IT1300055B1 (it) 2000-04-05

Family

ID=26045525

Family Applications (1)

Application Number Title Priority Date Filing Date
IT98MI000818A IT1300055B1 (it) 1998-02-01 1998-04-17 Eterocicli con anello a 5 termini difenil-sostituiti loro procedimento di preparazione e loro impiego come farmici

Country Status (10)

Country Link
US (1) US6255327B1 (enExample)
EP (1) EP1071670B1 (enExample)
JP (1) JP4589531B2 (enExample)
AT (1) ATE270665T1 (enExample)
CA (1) CA2322195C (enExample)
DE (2) DE19816880A1 (enExample)
ES (1) ES2224652T3 (enExample)
IT (1) IT1300055B1 (enExample)
MX (1) MXPA00009474A (enExample)
WO (1) WO1999054314A1 (enExample)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1070708B1 (en) * 1999-07-21 2004-01-14 F. Hoffmann-La Roche Ag Triazole derivatives
US6579880B2 (en) * 2000-06-06 2003-06-17 Ortho-Mcneil Pharmaceutical, Inc. Isoxazoles and oxadiazoles as anti-inflammatory inhibitors of IL-8
US6610723B2 (en) * 2001-01-29 2003-08-26 Hoffmann-La Roche Inc. Imidazole derivatives
US8829198B2 (en) * 2007-10-31 2014-09-09 Proteotech Inc Compounds, compositions and methods for the treatment of beta-amyloid diseases and synucleinopathies
GB0303503D0 (en) * 2003-02-14 2003-03-19 Novartis Ag Organic compounds
AU2004289694B2 (en) * 2003-11-10 2010-05-13 Merck Sharp & Dohme Corp. Substituted triazoles as sodium channel blockers
JP2007527917A (ja) * 2004-03-08 2007-10-04 ワイス イオンチャンネルモジュレーター
DOP2005000123A (es) * 2004-07-02 2011-07-15 Merck Sharp & Dohme Inhibidores de cetp
EP1815206B1 (en) 2004-10-13 2016-04-06 PTC Therapeutics, Inc. Compounds for nonsense suppression, and methods for their use
WO2008131148A1 (en) * 2007-04-19 2008-10-30 The Trustees Of The University Of Pennsylvania Diphenyl-heteroaryl derivatives and their use for binding and imaging amyloid plaques
WO2009111611A2 (en) 2008-03-05 2009-09-11 Proteotech Inc. Compounds, compositions and methods for the treatment of islet amyloid polypeptide (iapp) accumulation in diabetes
CN102060798A (zh) * 2011-01-04 2011-05-18 复旦大学 2-(1-氢-4-四唑)-4′- 甲基联苯及其衍生物的合成方法
US8865754B2 (en) 2011-03-03 2014-10-21 Proteotech Inc. Compounds for the treatment of neurodegenerative diseases
WO2016024587A1 (ja) * 2014-08-13 2016-02-18 日本曹達株式会社 ジアリールイミダゾール化合物および有害生物防除剤

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR5305E (fr) * 1905-06-17 1906-02-22 Edouard Pellorce Appareil électrique pour l'allumage des moteurs à explosion
DE1545806A1 (de) * 1951-01-28 1969-11-27 Hoechst Ag Verfahren zur Herstellung von heterocyclischen Verbindungen
FR1356901A (fr) * 1958-03-13 1964-04-03 Nouveaux aminoétheroxydes, aminothioéthers et aminoesters dérivés du pyrrole, etleur procédé de préparation
FR2152345A1 (en) * 1971-09-06 1973-04-27 Roussel Uclaf Alpha-(2-thiazolyl)oxyalkanoic acids and derivatives - - with analgesic,antiinflammatory and antipyretic activity
FR2244462A1 (en) * 1973-09-25 1975-04-18 Delalande Sa Antihypertensive, 5-hydroxy methyl 1,2,4-triazoles - prepd. from aniline and a hydroxy methyl 1,3,4-oxadiazole
SU753084A1 (ru) * 1979-03-23 1983-01-23 Ростовский Ордена Трудового Красного Знамени Государственный Университет Способ получени 1-[2-алкил(аралкил)аминоарил -4-арилимидазолов общей формулы
US4370336A (en) * 1979-06-11 1983-01-25 Gruppo Lepetit S.P.A. 3,5-Disubstituted-1H-1,2,4-triazole derivatives as antifertility agents
US4379155A (en) * 1979-06-11 1983-04-05 Gruppo Lepetit S.P.A. 3,5-Disubstituted-1H-1,2,4-triazole derivatives
US4826868A (en) * 1986-05-29 1989-05-02 Ortho Pharmaceutical Corporation 1,5-Diaryl-3-substituted pyrazoles pharmaceutical compositions and use
JP2928307B2 (ja) * 1989-02-03 1999-08-03 エーザイ株式会社 ピロリジン誘導体
CA2074933C (en) * 1990-11-30 2002-12-03 Masatoshi Chihiro Thiazole derivatives as active superoxide radical inhibitors
FR2678938B1 (fr) * 1991-07-10 1993-10-08 Rhone Poulenc Rorer Sa Derives de pyrrolidine, leur preparation et les medicaments les contenant.
IL104311A (en) * 1992-02-05 1997-07-13 Fujisawa Pharmaceutical Co Pyrazole derivatives, processes for the preparation thereof and pharmaceutical compositions containing the same
US5411977A (en) * 1993-03-31 1995-05-02 The Dupont Merck Pharmaceutical Company Substituted 2,5-diaryl-4-isothiazolin-3-ones as antiinflammatory and antithrombotic agents
DE19528189A1 (de) * 1995-08-01 1997-02-06 Basf Ag Benzolderivate mit einem heterocyclischen Rest
ATE240728T1 (de) * 1996-10-07 2003-06-15 Lilly Co Eli Neue verbindungen nutlich als neuroschützende mittel
DE19643037A1 (de) 1996-10-18 1998-04-23 Boehringer Ingelheim Kg Neue Oxadiazole, Verfahren zu ihrer Herstellung sowie deren Verwendung als Arzneimittel
WO1998027108A2 (en) * 1996-12-16 1998-06-25 Fujisawa Pharmaceutical Co., Ltd. New amide compounds and their use as nitric oxide synthase inhibitors

Also Published As

Publication number Publication date
WO1999054314A1 (de) 1999-10-28
CA2322195C (en) 2008-02-26
CA2322195A1 (en) 1999-10-28
ITMI980818A1 (it) 1999-10-17
JP2002512235A (ja) 2002-04-23
DE19816880A1 (de) 1999-10-21
US6255327B1 (en) 2001-07-03
ATE270665T1 (de) 2004-07-15
EP1071670B1 (de) 2004-07-07
JP4589531B2 (ja) 2010-12-01
EP1071670A1 (de) 2001-01-31
MXPA00009474A (es) 2002-08-12
ES2224652T3 (es) 2005-03-01
DE59909917D1 (de) 2004-08-12

Similar Documents

Publication Publication Date Title
AU2002234643A1 (en) Amphoteric liposomes and the use thereof
CY2010018I2 (el) Ενωσεις τυπου αμινοκυκλοεξυλο αιθερια και η χρηση των
AR027938A1 (es) Compuestos uracilo y utilizacion de los mismos
AU2001277731A1 (en) Fused bicyclic amide compounds and medicinal use thereof
IT1309590B1 (it) Derivati di 1-alcossi-polialchil-piperidine e loro impiego comeregolatori della polimerizzazione.
NO943888D0 (no) Farmasöytisk preparat
AU2710301A (en) Novel remedies with the use of beta3 agonist
AU2766097A (en) Acyl mercapto-triazolyl derivatives and the use thereof as microbicides
AU5373999A (en) New unsaturated oxime derivatives and the use thereof as latent acids
LV12624B (lv) Tienilazolilalkosietanamini to iegusanas panemiens un pielietojums medikamentu legusana
FR2758377B1 (fr) Bague d'etancheite coaxiale
ITMI941446A0 (it) Formulazioni a base di esculoside e loro uso in campo farmaceutico e cosmetico
AR025235A1 (es) FORMULACIoN DE UNA SUSPENSIoN ACUOSA ESTABLE ECTOPARASITICIDA QUE COMPRENDE ESPINOSINA, ARTíCULO DE FABRICACIoN QUE LA COMPRENDE Y SU USO PARA LA FABRICACIoN DE UN MEDICAMENTO
PL351617A1 (en) Substituted benzoylisoxazoles and the use thereof as herbicides
AU2001230355A1 (en) Benzoxazole derivatives and their use as pesticides
EE200100051A (et) Vastavast (-)-stereoisomeerist põhiliselt vaba (+)-nortsisapriidi või selle farmatseutiliselt vastuvõetava soola kasutamine ja farmatseutiline kompositsioon
PT1194038E (pt) Composicao de quebra do repouso e sua utilizacao
HUP0104238A3 (en) Benzoxazole derivatives and drugs containing the same as the active ingredient and their use
AU2001252627A1 (en) Polybenzasol fiber and use of the same
ITMI921514A0 (it) Polveri umidificabili fitofarmaceutiche e loro procedimento di preparazione
DE69934902D1 (de) Medikament gegen drogenabhängigkeit
AU1670800A (en) 1,2,3,4-tetrahydronaphthalenes and their pharmaceutical use
AU2597599A (en) The use of hiv-1 integrase in screening hiv-1 drug candidates
DE59805373D1 (de) Nephroprotektive Arzneimittel
AU2867001A (en) Benzoxazole derivatives and their use as pesticides

Legal Events

Date Code Title Description
0001 Granted